• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Abnormalities, Multiple

Abnormalities, Multiple - 435 Studies Found

Completed : Oxygen Versus Medical Air for Treatment of CSA in Prader Will Syndrome
:
  • Sleep Apnea, Central
  • Prader-Willi Syndrome

: 2017-01-20
: Biological: Medical Air vs Oxygen Medical Air/Oxygen will be given
Recruiting : Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study
:
  • Epidermolysis Bullosa Simplex
  • Epidermolysis Bullosa Simplex Kobner
  • Drug: Sirolimus, 2%
  • Drug: Vehicle

Completed : Setmelanotide Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity
:
  • Pro-opiomelanocortin (POMC) Deficiency Obesity (Heterozygous or Epigenetic)
  • Leptin Receptor
    : 2017-01-03
    : Drug: Setmelanotide RM-493 once daily subcutaneous injection
Completed : Treatment of Sleep Disturbances in School-age Children With Down Syndrome
: Down Syndrome
: 2015-11-30
:
  • Behavioral: Behavioral Sleep Treatment

Recruiting : The Effects of Inhalational Anaesthetics in Cognitive Functions in Down Syndrome Patients
: Down Syndrome
: 2016-11-11
:
  • Drug: Sevoflurane
  • Drug: Desflurane

Completed : A Safety and Pharmakokinetic Study of A4250 Alone or in Combination With A3384
:
  • Orphan Cholestatic Liver Diseases
  • Primary Biliary Cirrhosis
  • Drug: A4250
  • Drug: CRC (A3384)

Enrolling by invitation : FibroScan™ in Pediatric Cholestatic Liver Disease Study Protocol
:
  • Biliary Atresia
  • Alagille Syndrome
  • Alpha1 Anti-Trypsin Defi
    : 2016-09-20
    : Other: Liver Stiffness Measurement (LSM) LSM will be measured via transient elastography utilizing the n
Completed : Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome
:
  • Plasmacytoma
  • POEMS Syndrome

: 2016-09-26
:
  • Drug: Dexamethasone Given PO

Completed : Safety and Efficacy Study of NFC-1 in Subjects Aged 12-17 Years With 22q11.2DS & Associated Neuropsychiatric Conditions
: 22q11.2 Deletion Syndrome
: 2016-08-29
: Drug: NFC-1 Doses of NFC-1 will be administered as 50, 100, 200, or 400 mg twice daily as size 2, hard g
Active, not recruiting : Assessing the Feasibility of the Use of Visual Aids in Patient Education in Adults With Down Syndrome (DS)
: Down Syndrome
: 2016-08-27
:
  • Behavioral: Verbal instructions with picture diagram

<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.